Patents by Inventor Anders Hamberger

Anders Hamberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060286626
    Abstract: The present invention relates to chromophores for selective staining of cells or cell parts comprising a fluorescent chromophore of the general formulae I The invention further comprises a method for cell sorting, a method for cell targeting, as well as a method for cell identification.
    Type: Application
    Filed: December 6, 2004
    Publication date: December 21, 2006
    Inventors: Gunnar Westman, Eva Jennsiche, Anders Hamberger
  • Publication number: 20040192782
    Abstract: The present invention relates to compounds for the treatment and prevention of disease that are linked to disturbances and defects in the secretory system. Such diseases include diarrhea, Menière's disease, various kinds of edema, and so on. The inventors have shown that the compound erucamide can be used for such treatment. Use of a compound according to the formula (I), wherein R1 is a saturated or partly unsaturated straight or branched alkyl chain comprising 15-28, or preferably 19-24, carbon atoms or a pharmaceutically acceptable salt or solvate thereof, for the preparation of a pharmaceutical composition, to be used in the treatment of a mammal suffering from any of the conditions chosen from the group comprising; diarrhea, cerebral edema, Menières disease, ulcerative colitis or Crohn's disease.
    Type: Application
    Filed: May 14, 2004
    Publication date: September 30, 2004
    Inventors: Anders Hamberger, Gunnar Stenhagen
  • Patent number: 4962121
    Abstract: A method and composition is described for treating neurological diseases such as migraine, by influencing the nerve cells. This is achieved by optimizing the ability of the nerve cell gliacytes to transport taurine and the ability of the nerve cells to absorb taurine, by the external supply of amino acids occurring normally in the body. Preferred compositions include taurine, L-carnitine, zinc gluconate and calcium glycerophosphate.
    Type: Grant
    Filed: April 21, 1988
    Date of Patent: October 9, 1990
    Inventors: Anders Hamberger, Nico M. Van Gelder